Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
12,850
+140 (1.10%)
At close: May 12, 2025, 3:30 PM KST
KRX:007570 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 10,257 | -2,409 | 19,385 | 14,032 | 10,880 | Upgrade
|
Depreciation & Amortization | 9,824 | 11,971 | 11,767 | 11,227 | 12,664 | Upgrade
|
Other Amortization | - | - | - | 14.99 | 20.03 | Upgrade
|
Loss (Gain) From Sale of Assets | 9.54 | -0.51 | -21.22 | -2.86 | -137.47 | Upgrade
|
Asset Writedown & Restructuring Costs | -2.49 | -40.51 | 25.51 | -263.19 | 1,947 | Upgrade
|
Loss (Gain) From Sale of Investments | -27.43 | -30.57 | 24.78 | - | 123.55 | Upgrade
|
Loss (Gain) on Equity Investments | -2,083 | 13,425 | -10,754 | -9,236 | - | Upgrade
|
Provision & Write-off of Bad Debts | -52.33 | -393.8 | -964.92 | 1,067 | 98.4 | Upgrade
|
Other Operating Activities | 1,901 | 3,604 | 2,427 | 16,825 | 2,683 | Upgrade
|
Change in Accounts Receivable | 1,098 | -1,087 | 3,101 | -10,261 | 3,085 | Upgrade
|
Change in Inventory | -7,606 | -5,574 | -16,830 | 5,719 | 5,929 | Upgrade
|
Change in Accounts Payable | -3,545 | -3,425 | 6,502 | 4,160 | -1,746 | Upgrade
|
Change in Income Taxes | - | - | - | - | 10,055 | Upgrade
|
Change in Other Net Operating Assets | -4,157 | -1,421 | -8,779 | 18,147 | 11,883 | Upgrade
|
Operating Cash Flow | 5,615 | 14,619 | 5,883 | 51,429 | 57,484 | Upgrade
|
Operating Cash Flow Growth | -61.59% | 148.49% | -88.56% | -10.53% | 58.83% | Upgrade
|
Capital Expenditures | -38,200 | -5,883 | -3,946 | -12,371 | -10,174 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.52 | 20 | 0.92 | - | Upgrade
|
Divestitures | - | - | - | - | 3,637 | Upgrade
|
Sale (Purchase) of Intangibles | -2,423 | -949.74 | -12.08 | -2,128 | -14,447 | Upgrade
|
Investment in Securities | 3,365 | -4,606 | 28,115 | -565.4 | -117.09 | Upgrade
|
Other Investing Activities | 82.53 | -77.65 | -14 | 366.7 | -74.36 | Upgrade
|
Investing Cash Flow | -37,175 | -11,516 | 24,163 | -14,671 | -21,160 | Upgrade
|
Short-Term Debt Issued | 68,716 | 24,789 | 35,000 | 39,147 | - | Upgrade
|
Long-Term Debt Issued | 8,700 | 6,000 | - | - | - | Upgrade
|
Total Debt Issued | 77,416 | 30,789 | 35,000 | 39,147 | - | Upgrade
|
Short-Term Debt Repaid | -42,000 | -30,000 | -56,500 | -31,147 | -13,412 | Upgrade
|
Long-Term Debt Repaid | -717.18 | -2,753 | -3,737 | -10,758 | -12,506 | Upgrade
|
Total Debt Repaid | -42,717 | -32,753 | -60,237 | -41,905 | -25,918 | Upgrade
|
Net Debt Issued (Repaid) | 34,699 | -1,965 | -25,237 | -2,758 | -25,918 | Upgrade
|
Issuance of Common Stock | 515.48 | - | - | - | - | Upgrade
|
Repurchase of Common Stock | - | -2,000 | -3,000 | - | - | Upgrade
|
Dividends Paid | -2,974 | -2,992 | -3,942 | -2,350 | -4,902 | Upgrade
|
Other Financing Activities | -0.56 | -22 | 183.5 | -31,524 | -141.56 | Upgrade
|
Financing Cash Flow | 32,240 | -6,978 | -31,996 | -36,632 | -30,961 | Upgrade
|
Foreign Exchange Rate Adjustments | 201.72 | 115.33 | -164.64 | - | 82.48 | Upgrade
|
Net Cash Flow | 881.17 | -3,759 | -2,115 | 125.49 | 5,446 | Upgrade
|
Free Cash Flow | -32,585 | 8,736 | 1,938 | 39,057 | 47,310 | Upgrade
|
Free Cash Flow Growth | - | 350.88% | -95.04% | -17.44% | 39.07% | Upgrade
|
Free Cash Flow Margin | -12.12% | 3.28% | 0.78% | 16.11% | 13.78% | Upgrade
|
Free Cash Flow Per Share | -1769.45 | 475.15 | 106.90 | 2145.40 | 2598.70 | Upgrade
|
Cash Interest Paid | 3,634 | 3,312 | 2,096 | 1,912 | 3,073 | Upgrade
|
Cash Income Tax Paid | 1,598 | 1,239 | 5,108 | 1,320 | 15,299 | Upgrade
|
Levered Free Cash Flow | -37,190 | 10,211 | -1,037 | 34,080 | 25,857 | Upgrade
|
Unlevered Free Cash Flow | -35,358 | 12,227 | 295.86 | 35,249 | 27,722 | Upgrade
|
Change in Net Working Capital | 11,433 | 3,148 | 16,419 | -29,028 | -18,367 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.